Literature DB >> 4735589

Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.

J W Yunginger, G J Gleich.   

Abstract

Seasonal changes in IgE antibodies and their relationship to IgG antibodies were studied in 52 patients with ragweed hay fever and 10 normal controls. Allergic patients received either no immunotherapy, preseasonal immunotherapy, or high dose perennial immunotherapy with aqueous-mixed ragweed extract. Serums were collected before, during, just after, and 4 mo after the ragweed pollination season. IgE antibodies to ragweed antigen E (AgE) were measured using the radioallergosorbent test, and IgG antibodies were measured by radioimmunoprecipitation.IgE antibodies to AgE were elevated in all allergic patients, and rose during the ragweed pollination season. The magnitude of the rise in IgE antibody was a function of the preseasonal IgE antibody level. IgE antibody production in the treated groups was the same as in the untreated group when patients were matched on the basis of their preseasonal IgE antibody levels. Thus, we were not able to confirm previous reports that immunotherapy suppresses the seasonal rise in IgE antibodies. Furthermore, there was a close relationship between the levels of IgE and IgG antibodies in the high dose group. This finding is contrary to what one would expect were IgG antibodies acting to suppress the formation of IgE antibodies. Rather, it suggests that in certain patients either humoral immunological reactivity to ragweed antigens in the IgG and IgE classes is low to begin with or that this reactivity may wane after treatment with high doses of ragweed extract.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735589      PMCID: PMC302383          DOI: 10.1172/JCI107294

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization.

Authors:  L M Lichtenstein; P S Norman; W L Winkenwerder; A G Osler
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

2.  Comparison of the protein-binding capacities of cyanogen bromide-activated polysaccharides.

Authors:  J W Yunginger; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1972-08       Impact factor: 10.793

3.  Measurement of IgE in normal and allergic serum by radioimmunoassay.

Authors:  G J Gleich; A K Averbeck; H A Swedlund
Journal:  J Lab Clin Med       Date:  1971-04

4.  A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody.

Authors:  L M Lichtenstein; N A Holtzman; L S Burnett
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

5.  Human reaginic antibodies and immunoglobulin E.

Authors:  K Ishizaka; T Ishizaka
Journal:  J Allergy       Date:  1968-12

6.  Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement.

Authors:  N Sadan; M B Rhyne; E D Mellits; E O Goldstein; D A Levy; L M Lichtenstein
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

7.  Seasonal changes in serum and nassal IgE concentrations.

Authors:  J W Yunginger; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1973-03       Impact factor: 10.793

8.  In vitro diagnosis of atopic allergy. 3. Quantitative estimation of circulating IgE antibodies by the radioallergosorbent test.

Authors:  S G Johansson; H Bennich; T Berg
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

9.  Suppression of reagin synthesis in rabbits by passively administered antibody.

Authors:  O Strannegård; L Belin
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

10.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

View more
  10 in total

Review 1.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  The effects of PG102, a water-soluble extract from Actinidia arguta, on serum total IgE levels: a double-blind, randomized, placebo-controlled exploratory clinical study.

Authors:  Sae-Hoon Kim; Sunyoung Kim; So-Hee Lee; Heung-Woo Park; Yoon-Seok Chang; Kyung-Up Min; Sang-Heon Cho
Journal:  Eur J Nutr       Date:  2010-12-25       Impact factor: 5.614

3.  Quantitative relationships between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E.

Authors:  C R Zeiss; W J Metzger; D Levitz
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

4.  IgG and IgE antibodies to Chironomidae in asthmatic patients.

Authors:  N Yamashita; K Ito; T Nakagawa; M Haida; H Okudaira; S Nakada; T Miyamoto; T Shibuya; K Kamei; M Sasa
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

Review 5.  In vitro allergy testing. Past, present, and future.

Authors:  L L Perelmutter
Journal:  Clin Rev Allergy       Date:  1994

6.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

Authors:  G O Solley; G J Gleich; R E Jordon; A L Schroeter
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

7.  Detection of IgE insulin antibody with radioallergosorbent test.

Authors:  S Nakagawa; N Saito; H Nakayama; T Sasaki; T Watanabe; S Aoki
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

Review 8.  The production and regulation of IgE by the immune system.

Authors:  Lawren C Wu; Ali A Zarrin
Journal:  Nat Rev Immunol       Date:  2014-03-14       Impact factor: 53.106

9.  Failure of hyposensitisation in treatment of children with grass-pollen asthma.

Authors:  D J Hill; C S Hosking; M J Shelton; M W Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

10.  Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells.

Authors:  Andrew C Nyborg; Anna Zacco; Rachel Ettinger; M Jack Borrok; Jie Zhu; Tom Martin; Rob Woods; Christine Kiefer; Michael A Bowen; E Suzanne Cohen; Ronald Herbst; Herren Wu; Steven Coats
Journal:  Cell Mol Immunol       Date:  2015-03-23       Impact factor: 11.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.